Alis Burciu

Immunochemotherapy With Obinutuzumab or Rituximab for Previously Untreated Follicular Lymphoma in the GALLIUM Study: Influence of Chemotherapy on Efficacy and Safety

Wolfgang Hiddemann, Anna Maria Barbui, Miguel Canales et al. · Journal of Clinical Oncology · 2018 · 234 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +16

Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials

Marcus Maurer, Luís Felipe Ensina, Ana M. Giménez‐Arnau et al. · The Lancet · 2023 · 64 citations

Life Sciences, Dermatology, Pharmacotherapy +8

Sustained safety and efficacy of ligelizumab in patients with chronic spontaneous urticaria: A one‐year extension study

Marcus Maurer, Ana M. Giménez‐Arnau, Jonathan A. Bernstein et al. · Allergy · 2021 · 39 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +17

IMMUNOCHEMOTHERAPY WITH OBINUTUZUMAB OR RITUXIMAB IN a SUBSET OF PATIENTS IN THE RANDOMISED GALLIUM TRIAL WITH PREVIOUSLY UNTREATED MARGINAL ZONE LYMPHOMA (MZL)

Michael Herold, Eva Hoster, Ann Janssens et al. · Hematological Oncology · 2017 · 22 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Ligelizumab in adolescents with chronic spontaneous urticaria: Results of a dedicated phase 2b randomized clinical trial supported with pharmacometric analysis

Petra Staubach, Montserrat Álvaro‐Lozano, Bülent Enis Şekerel et al. · Pediatric Allergy and Immunology · 2023 · 18 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17